NEW YORK (Reuters Health) – For primary percutaneous coronary intervention for ST-segment elevation MI, access via the radial artery is associated with better outcomes than is the femoral…
NEW YORK (Reuters Health) – In a phase 2 study of maintenance therapy for metastatic colorectal cancer, adding enzastaurin to bevacizumab plus bolus and infusional 5-fluorouracil-leucovorin (LV5FU2) did…
NEW YORK (Reuters Health) – For patients with significant mitral valve regurgitation who are not considered candidates for surgery, catheter-based mitral leaflet repair with the MitraClip device (Abbott…
NEW YORK (Reuters Health) – For patients with atrial fibrillation (AF) on long-term warfarin therapy, an interruption in treatment more than doubles the risk of death or a…
NEW YORK (Reuters Health) – Neither the frequency nor the duration of upper respiratory infections (URIs) in preschoolers are reduced by prophylactic treatment with montelukast, according to the…
NEW YORK (Reuters Health) – Profoundly deaf children given bilateral cochlear devices have significantly better spoken language abilities than those given a single implant, according to a report…
NEW YORK (Reuters Health) – Sublingual and oral immunotherapy may help some children with milk allergy, but clinical desensitization is quickly lost and systemic reactions occur with oral…
NEW YORK (Reuters Health) – The effects of an H1 receptor antagonist in reducing allergen-induced nasal symptoms appear to be enhanced with the addition of an H3 receptor…
NEW YORK (Reuters Health) – Three years of weekly treatment with a sustained-release formulation of growth hormone is as safe and effective as standard daily growth hormone (GH)…
NEW YORK (Reuters Health) – Patients requiring chronic nonsteroidal anti-inflammatory drug (NSAID) treatment develop fewer gastric or duodenal ulcers if they take ibuprofen with high-dose famotidine in a…
